PTPRJ has been implicated in breast, colon, lung and thyroid cancers [37], and it is expressed by all resting leukocytes and upregulated following in vitro stimulation, thus it appears to be a T cell activating molecule [38]. The gene discussed is PTPRJ; the disease is thyroid gland carcinoma.